XML 81 R61.htm IDEA: XBRL DOCUMENT v3.22.2.2
Revenue - Revenue by Type (Details) - USD ($)
$ in Millions
12 Months Ended
Sep. 24, 2022
Sep. 25, 2021
Sep. 26, 2020
Disaggregation of Revenue [Line Items]      
Revenues $ 4,862.8 $ 5,632.3 $ 3,776.4
Diagnostics      
Disaggregation of Revenue [Line Items]      
Revenues 3,018.5 3,695.0 2,102.1
United States      
Disaggregation of Revenue [Line Items]      
Revenues 3,467.9 3,902.3 2,863.2
United States | Diagnostics      
Disaggregation of Revenue [Line Items]      
Revenues 2,027.3 2,393.1 1,582.4
International      
Disaggregation of Revenue [Line Items]      
Revenues 1,394.9 1,730.0 913.2
International | Diagnostics      
Disaggregation of Revenue [Line Items]      
Revenues 991.2 1,301.9 519.7
Consumables      
Disaggregation of Revenue [Line Items]      
Revenues 3,603.6 4,198.2 2,561.1
Capital equipment, components and software      
Disaggregation of Revenue [Line Items]      
Revenues 587.6 769.1 665.9
Service      
Disaggregation of Revenue [Line Items]      
Revenues 652.4 598.1 516.6
Other      
Disaggregation of Revenue [Line Items]      
Revenues 19.2 66.9 32.8
Cytology & Perinatal | Diagnostics      
Disaggregation of Revenue [Line Items]      
Revenues 474.7 473.9 410.1
Cytology & Perinatal | United States | Diagnostics      
Disaggregation of Revenue [Line Items]      
Revenues 300.4 304.6 266.3
Cytology & Perinatal | International | Diagnostics      
Disaggregation of Revenue [Line Items]      
Revenues 174.3 169.3 143.8
Molecular Diagnostics | Diagnostics      
Disaggregation of Revenue [Line Items]      
Revenues 2,511.4 3,171.5 1,648.4
Molecular Diagnostics | United States | Diagnostics      
Disaggregation of Revenue [Line Items]      
Revenues 1,694.5 2,038.9 1,272.5
Molecular Diagnostics | International | Diagnostics      
Disaggregation of Revenue [Line Items]      
Revenues 816.9 1,132.6 375.9
Blood screening [Member] | Diagnostics      
Disaggregation of Revenue [Line Items]      
Revenues 32.4 49.6 43.6
Blood screening [Member] | United States | Diagnostics      
Disaggregation of Revenue [Line Items]      
Revenues 32.4 49.6 43.6
Blood screening [Member] | International | Diagnostics      
Disaggregation of Revenue [Line Items]      
Revenues $ 0.0 $ 0.0 $ 0.0